34
Participants
Start Date
May 31, 2010
Primary Completion Date
June 30, 2014
Study Completion Date
June 30, 2014
apremilast
30 mg BID apremilast taken orally for the first 12 weeks followed by responders randomized to either 30 mg BID apremilast (oral) or 30 mg BID placebo (oral) for 8 weeks
Placebo
Baylor Research Institute - Arthritis Care and Research Center, Dallas
Lead Sponsor
Baylor Research Institute
OTHER